The Regulating Effect of Autophagy-Related MiRNAs in Kidney, Bladder, and Prostate Cancer

Kai Huang1, Xiaoxin Sun2, Haotian Wu1

  • 1Department of Urology, First Affifiliated Hospital of Dalian Medical University, Dalian, China.

Journal of Oncology
|May 12, 2021
PubMed

Insights

Autophagy-related microRNAs (miRNAs) are crucial in cancer, including urinary system tumors. This review explores their regulatory roles in kidney, bladder, and prostate cancers, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Autophagy is a key cellular process and a therapeutic target for various diseases, notably cancer.
  • MicroRNAs (miRNAs) are increasingly recognized for their regulatory roles in cancer development and treatment.
  • Autophagy-related miRNAs have demonstrated significant involvement in multiple cancer types, influencing treatment resistance.

Purpose of the Study:

  • To review the regulatory functions of autophagy-related miRNAs in urinary system tumors.
  • To identify novel therapeutic targets for kidney, bladder, and prostate cancers.
  • To provide insights into the role of miRNAs in modulating autophagy within the urinary tract.

Main Methods:

  • Literature review of studies on autophagy, miRNAs, and urinary system cancers.
  • Analysis of specific autophagy-related miRNAs (e.g., miR-495, miR-30, miR-101) and their targets.
  • Synthesis of current research on miRNA-mediated autophagy regulation in kidney, bladder, and prostate cancer.

Main Results:

  • Autophagy-related miRNAs play a significant role in the progression and resistance of gastric, lung, and cervical cancers.
  • Emerging evidence highlights the involvement of these miRNAs in the autophagy of kidney, bladder, and prostate cancers.
  • Specific miRNAs are associated with autophagy modulation in these urinary system malignancies.

Conclusions:

  • Autophagy-related miRNAs represent promising therapeutic targets for urinary system cancers.
  • Understanding miRNA-autophagy interactions can lead to innovative treatment strategies for kidney, bladder, and prostate cancer.
  • Further research into these miRNAs may unlock new avenues for targeted cancer therapy.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K